Consenso | Avanço na agenda de saúde pública global para doença hepática gordurosa não alcoólica.

Advancing the global public health agenda for NAFLD: a consensus statement – Nature Reviews Gastroenterology & Hepatology

Conteúdos relacionados:

Clinical Care Pathway for the Risk Stratification and Management of Patients with Nonalcoholic Fatty Liver Disease.

Non-alcoholic fatty liver disease: A patient guideline.

State of the art review: Management of non-alcoholic fatty liver disease

M-A: Non-alcoholic fatty liver disease linked to increased risk of fatal and non-fatal cardiovascular events.

M-A: non-invasive tests for advanced fibrosis can reduce the need for biopsy in patients with non-alcoholic fatty liver disease.

Review: Dietary carbohydrates and fats in nonalcoholic fatty liver disease.

Comentário no Twitter

A Consensus Statement published in @NatRevGastroHep discusses recommendations for tackling the burden of non-alcoholic fatty liver disease. https://t.co/eX7Ht53DOB pic.twitter.com/lHKsfQmSj3

— Nature Portfolio (@NaturePortfolio) November 6, 2021